Vistas y estadísticas descargadas: Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Mapa geográfico
| Región | Cantidad |
|---|---|
| AS - Asia, otros | 169 |
| NA - América del Norte | 115 |
| EU - Europa | 78 |
| AF - Africa | 11 |
| OC - Oceanía | 8 |
| SA - América del Sur | 3 |
| Desconocido | 3 |
| Total | 387 |
| País | Cantidad |
|---|---|
| US - Estados Unidos de América | 107 |
| CN - China | 90 |
| GB - Reino Unido | 29 |
| JP - Japón | 25 |
| HK - Hong Kong | 13 |
| DE - Alemania | 12 |
| IN - India | 9 |
| CA - Canadá | 8 |
| AU - Australia | 7 |
| FR - Francia | 7 |
| other - Otro País | 80 |
| Total | 387 |
| Ciudad | Cantidad |
|---|---|
| Ashburn | 22 |
| Shanghai | 10 |
| Beijing | 8 |
| London | 6 |
| Hanoi | 5 |
| Boardman | 4 |
| Hangzhou | 4 |
| Harbin | 4 |
| Lockerbie | 4 |
| Singapore | 4 |
| other | 258 |
| Total | 329 |
| Nombre del archivo | Cantidad |
|---|---|
| 199839 - 1-s2.0-S1470204519308010-main.pdf - ITEM:( 10553/71977) | 387 |
| Total | 387 |
| Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 2 | 1 | 3 | 9 |
| 2024 | 5 | 6 | 14 | 15 | 7 | 13 | 37 | 34 | 29 | 30 | 49 | 51 | 290 |
| 2025 | 20 | 21 | 22 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 |
| TOTAL | 387 | ||||||||||||